Sahar Abubucker

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• A novel epigenetic editor targeting PCSK9 achieves maximal pharmacological effect with an increased therapeutic window in non-human primates

  Atherosclerosis · 2025-07-18

• A potent epigenetic editor targeting human PCSK9 for durable reduction of low-density lipoprotein cholesterol levels

  Nature Medicine · 2025-02-10 · 83 citations

• An epigenetic editor targeting human PCSK9 efficiently and durably lowers Low Density Lipoprotein Cholesterol (LDL-C) in non-human primates

  European Heart Journal · 2024-10-01 · 2 citations